U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07459933) titled 'Topical Methotrexate vs Minoxidil for Localized Alopecia Areata' on March 04.
Brief Summary: Alopecia areata is an autoimmune disorder characterized by well-defined, non-scarring patches of hair loss on the scalp and other hair-bearing areas. Although several treatment options are available, there is no universally accepted standard therapy, and treatment responses vary widely among patients.
Minoxidil is commonly used for hair regrowth due to its ability to stimulate hair follicles and prolong the anagen phase of the hair cycle. Methotrexate, an immunosuppressive agent traditionally used in inflammatory and autoimmune diseases, h...